TAVEGYL cpr 1 mg 20 pce

7680336670356 CH-33667 R06AA04 07.13.1.
TAVEGYL cpr 1 mg 20 pce
TAVEGYL cpr 1 mg 20 pce
TAVEGYL cpr 1 mg 20 pce
1 / 3
google

Details

Product number
3366701
CPT
-
Packaging group
20
Unit
Tablette(n)
Composition
clemastinum 1 mg ut clemastini fumaras, magnesii stearas, povidonum, talcum, maydis amylum, lactosum monohydricum 107.66 mg, pro compresso.

Articles (1)

Tavegyl, Tabletten
Tabletten
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
31/08/2021
Patient information leaflet
Français
31/08/2021
Patient information leaflet
Italien
31/08/2021
Professional SmPC
Allemand
31/08/2021
Professional SmPC
Français
31/08/2021
Professional SmPC
Italien
31/08/2021

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
107.66 MG Substance HBESI

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
33667
Drug name
Tavegyl, Tabletten
Galenic form
TAB
ATC Code
R06AA04
Authorization status
Z
Dispensation category
D
First authorization
17/10/1967
Authorization expiration date
31/12/9999
IT number
07.13.1.
Domain
Human medicine
Field of application
Antihistaminikum

Packaging details

Description (FR)
TAVEGYL cpr 1 mg 20 pce
Description (DE)
TAVEGYL Tabl 1 mg 20 Stk
Market launch
17/10/1967
Narcotic (BTM)
No